Brock Reeve is the CEO of EOS BioInnovation, an investment company launched in 2022 to accelerate the formation of companies in the regenerative medicine field. EOS is dedicated to incubating and seeding companies across modalities and indications based on research from leading academic labs. Prior to forming EOS, Brock was the Executive Director of the Harvard Stem Cell Institute. Brock came to HSCI from the commercial sector with extensive experience in both management consulting and operations for life science and medical device companies. Brock was the initial CEO of IVIVA Medical (recently acquired) and is on the Board of Thrive Bioscience and a Board observer at Axonis Therapeutics.